Skip to content
Use caution Drug recall · FDA · Published October 27, 2017

Fresenius Kabi Midazolam Syringes Recalled Due to Label Mix-Up

Fresenius Kabi recalls 24-pack midazolam injection syringes that are mislabeled with ondansetron instead. This mix-up could lead to incorrect medication use. Consumers should check their syringes and contact the company for details.

🇺🇸 FDA recall #D-0152-2018DrugFresenius Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC5200 Corporate Pkwy · Wilson, NC 27893-9412
✎ GovInfoNow plain-language explainer

Fresenius Kabi is recalling 24-pack midazolam injection syringes that are mislabeled as containing ondansetron instead. This mix-up could cause patients to receive the wrong medication, which may lead to serious health risks. Read more at govinfonow.com/recall/41117-fresenius-kabi-midazolam-syringes-recalled-due-to-label-mix-up.

Source Summary by GovInfoNow · govinfonow.com/recall/41117-fresenius-kabi-midazolam-syringes-recalled-due-to-label-mix-up · Updated October 7, 2026 · FDA enforcement record: FDA #D-0152-2018

Cite this page

“Fresenius Kabi Midazolam Syringes Recalled Due to Label Mix-Up.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41117-fresenius-kabi-midazolam-syringes-recalled-due-to-label-mix-up. Based on FDA recall #D-0152-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0152-2018%22&limit=1).

Fresenius Kabi USA, LLC voluntarily recalled Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL prefilled syringes due to a labeling mix-up hazard, according to the FDA. The agency announced the recall on October 27, 2017.

How to tell if you have it

  • Brand: Fresenius Kabi
  • Product: Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton
  • NDC: 76045-001-20
  • Lot code: 6400048

The hazard

The blister packages labeled as Midazolam injection, USP, 2 mg / 2 ml contained syringes of Ondansetron Injection, USP, 4 mg / 2 mL. This labeling mix-up poses a risk of incorrect medication administration.

Context

GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since September 27, 2012. Other recent recalls include the Fresenius Kabi Tyenne Injection recall for glass particles (August 10, 2026), the Fresen Morphine Syringes labeling error (August 4, 2026), and the Fresenius Kabi Xylocaine 1% Injection hair particulate hazard (July 16, 2026). Other recent recalls of similar products include the Ajanta Pharma Aripiprazole Tablets mix-up risk (May 27, 2026), the American Health Packaging Buprenorphine Tablets label mix-up (August 19, 2026), and the Annora Pharma Lacosamide Tablets possible Selexipag mix-up (June 4, 2026).

How to tell if you have this one

Check for blister packs labeled as 'Midazolam injection, USP, 2 mg / 2 ml' that contain syringes of ondansetron. The product was sold with NDC 76045-001-20 and lot number 6400048.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Syringe Label

    Look for blister packs labeled as Midazolam injection, USP, 2 mg / 2 ml that contain ondansetron syringes instead.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.9 years after the firm started it.

1. Firm started the recall: Oct 27, 201712. FDA classified it Class I: Jan 4, 201823. Published in FDA’s Enforcement Report: Jan 10, 201834. FDA terminated the recall: Oct 5, 2020420172020
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the product being recalled?

Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton.

Similar recalls

Other Fresenius Kabi recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0152-2018 (October 27, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0152-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA